Holen Sie sich die Stockscreener-App
80.23
0.62%
-0.4749
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$80.70
Offen:
$80.96
24-Stunden-Volumen:
3.36M
Relative Volume:
0.48
Marktkapitalisierung:
$101.78B
Einnahmen:
$393.94B
Nettoeinkommen (Verlust:
$428.00M
KGV:
209.68
EPS:
0.3826
Netto-Cashflow:
$6.29B
1W Leistung:
+1.06%
1M Leistung:
+6.04%
6M Leistung:
+20.28%
1J Leistung:
+75.18%
1-Tages-Spanne:
$80.08
$81.34
1-Wochen-Bereich:
$78.22
$81.75
52-Wochen-Spanne:
$44.92
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
80.18 | 102.44B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
UNH
Unitedhealth Group Inc
|
341.20 | 316.11B | 435.16B | 18.37B | 17.37B | 19.16 |
|
ELV
Elevance Health Inc
|
368.02 | 82.53B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
279.95 | 76.07B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
278.18 | 33.66B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Cantor favors CVS and UNH for Medicare Advantage exposure in 2026 - Investing.com
The Truth About CVS Health Corp: Is This Quiet Giant Suddenly a Must?Cop Stock? - AD HOC NEWS
Are CVS, UnitedHealth, Cigna Hiding Billions In PBM Rebates? New Report Claims They Are - Benzinga
CVS, UnitedHealth, Cigna accused of diverting billions via shell firms - Investing.com
CVS Might Have to Fight Aetna Investor’s Appealed Disclosure Row - Bloomberg Law News
“Bullshit” — The New Way Health Giants Hide Billions - Hunterbrook
Southington, Glastonbury file federal lawsuits claiming diabetes drug manufacturers, PBMs collude on prices - Hartford Business Journal
CVS (CVS) Maintains Quarterly Dividend of $0.665 Per Share - GuruFocus
CVS Health declares quarterly dividend of $0.665 per share By Investing.com - Investing.com Canada
CVS Health will pay shareholders 66.5 cents per share in February - Stock Titan
CVS Health Corporation (NYSE:CVS) is favoured by institutional owners who hold 88% of the company - simplywall.st
Are CVS, UnitedHealth, and Cigna Concealing Billions in PBM Rebates? A Recent Report Alleges They Are - Bitget
CVS Health Corporation $CVS Shares Bought by Alpha Omega Wealth Management LLC - MarketBeat
CVS Health Corp.: Can America’s Pharmacy Super-App Strategy Beat Amazon and Walmart? - AD HOC NEWS
JPMorgan Names CVS a Top Pick as Turnaround Gains Traction - Finviz
10 Top-Performing Dividend Stocks of 2025 - Morningstar
CVS Health (CVS) Poised for Continued Growth in 2026 - GuruFocus
CVS, Astra, Cardinal to continue record setting rally into 2026: Barron’s - Seeking Alpha
Insiders Scoop Unveiling The Lucrative Potential Of Cvs Health Director Salary Salaries Levels Fyi - shababeek.org
Econ Financial Services Corp Takes Position in CVS Health Corporation $CVS - MarketBeat
Unlocking The Secrets Of Cvs Health Director Salary A Comprehensive Guide Org Chrt In 2023 Dtbhn - shababeek.org
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock - Yahoo Finance
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
CVS Gets Higher Target as Bernstein Cites Management Confidence - Finviz
Peering Into CVS Health Corp's Recent Short Interest - Benzinga
Perigon Wealth Management LLC Grows Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Farmers & Merchants Investments Inc. - MarketBeat
Where is CVS Health Corporation (CVS) Headed According to Analysts? - Insider Monkey
CVS Health Corp.: Between Turnaround Hopes and Margin Squeeze, the Stock Walks a Tightrope - AD HOC NEWS
CVS Health Corp.: Dividend Doubts, Strategy Shifts and a Market Struggling to Believe - AD HOC NEWS
10 Best Affordable Healthcare Stocks to Buy Now - Insider Monkey
Rimfrost Patent Suit Targets Aker’s Krill Oil in CVS Supplements - Bloomberg Law News
Brookstone Capital Management Has $2.40 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Burney Co. Sells 45,923 Shares of CVS Health Corporation $CVS - MarketBeat
Check out CVS Health Corp's stock price (CVS-CA) in real time - CNBC
Canoe Financial LP Has $128.51 Million Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Exchange Traded Concepts LLC Grows Position in CVS Health Corporation $CVS - MarketBeat
Are Markets Open On Christmas? Here's What's Open, What's Closed On December 25 - Benzinga
CVS Stock After the Bell (Dec. 24, 2025): CVS Health Dips in After‑Hours Holiday Trade—Key News, Forecasts, and What to Watch Before the Next Open - ts2.tech
CVS Health Corp (TSX:CVS) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CVS Health (CVS) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS/Aetna Medicare Advantage Plans Policy Holders Have - GlobeNewswire
Value Partners Investments Inc. Cuts Stock Holdings in CVS Health Corporation $CVS - MarketBeat
CVS Health's (NYSE:CVS) investors will be pleased with their notable 84% return over the last year - Yahoo Finance
J&J Unit, CVS Take Aim at Big False Claims Act Judgments in 2026 - Bloomberg Law News
Yousif Capital Management LLC Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
Patton Fund Management Inc. Acquires 61,440 Shares of CVS Health Corporation $CVS - MarketBeat
Rep. Dwight Evans Sells CVS Health Corporation (NYSE:CVS) Shares - MarketBeat
USA Financial Formulas Lowers Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Wedge Capital Management L L P NC Lowers Stake in CVS Health Corporation $CVS - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):